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Abstract 
 
Mild Traumatic Brain Injuries (mTBIs) and Post Traumatic Stress Disorder 
(PTSD) are two of the signature wounds of war.  Due to the advances in technology the 
survival rates are higher than in previous wars, however, the weaponry has changed.  The 
world has seen an increase in the use of suicide bombs, improvised explosive devices 
(IEDs) and rocket propelled grenades (RPGs) which increases the number of blast related 
injuries. One of the major problems with blast related injuries is that they can be invisible 
to the naked eye.  The lack of physical evidence suggests the soldier is not injured and 
can be sent back into battle, when there could be an undetected internal injury. 
Due to the overlap in symptoms, many soldiers are being treated for PTSD instead 
of mTBI, which can cause long-term damage.  In order to shed light on this issue, this 
thesis evaluates 2007-2008 active duty medical costs to determine the costs the PTSD 
and mTBI.  The findings suggest that mTBI and PTSD account for .53% and 1.8%, 
respectively, of the 2008 population data sample.  While this may seem like a small 
percentage this was only two months of data.  However, it is important to properly 
diagnose mTBI and PTSD because these illnesses could cost the military member 
thousands of dollars in out of pocket medical costs. 
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THE COST OF TREATING POST TRAUMATIC STRESS DISORDER                  
AND MILD TRAUMATIC BRAIN INJURIES 
 
 
Chapter I:   Introduction 
 
Background 
Posttraumatic Stress Disorder (PTSD) and Traumatic Brain Injuries (TBI) are the 
signature wounds of war for Operation Iraqi Freedom (OIF) and Operation Enduring 
Freedom (OEF).  “With advances in body armor technology and acute trauma care, many 
military service members are now surviving injuries that would have been fatal in 
previous wars” (Lew, Cifu, Sigford, Scott, Sayer, & Jaffee, 2007).  The injuries sustained 
may be invisible to the naked eye, to other service members, family members, and 
society in general.  Without recognition of the injuries the recovery can be prolonged and 
cause family problems, employment problems and even societal problems.   Due to the 
increase in survival rates the Department of Defense (DoD) needed to provide proper 
medical care and in the August 2008 edition of the Air Force Times it was reported that 
the DoD would spend an “unprecedented $300 million this summer on research for post 
traumatic stress disorder and traumatic brain injury, offering hope not only for troops but 
hundreds of thousands of civilians” (Zoroya, 2008).   
The cost of the Iraq and Afghanistan wars are continually increasing and to date 
the DoD has allocated $1.05 trillion since the time of inception (Cost of War).  In 
December 2008, Ms. Linda Bilmes stated at the 133
rd
 Annual Meeting of the American 
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Neurological Association that “long-term medical care and disability benefits to veterans 
is projected to cost about $700 billion.  With the inclusion of medical expenses for 
veterans with neurologic and neuropsychiatric disorders, such as TBI and PTSD, the 
costs of long-term medical care are likely to surpass the operating costs of the war” 
(Jannicelli, 2008). 
The recent conflicts have created problems for doctors due to the increased 
likelihood of exposure to high-energy explosions and blasts.  Rocket-propelled grenades, 
improvised explosive devices, explosively formed projectiles and land mines create these 
explosions or blasts.  Currently in Operation Enduring Freedom and Operation Iraqi 
Freedom (OEF/OIF), upward of 78% of combat injuries are the result of explosive 
munitions (Owens, Kragh, Wenke, Macaitis, Wade, & Holcomb, 2008).  The equipment 
the services issue is protecting the soldiers enough to save their lives, but is leaving some 
of the soldiers with complex medical issues.  The TBI definition proposed by the 
American Congress of Rehabilitation Medicine includes (1) associated diminished or 
altered state of or loss of consciousness (LOC); (2) posttraumatic amnesia for less than 24 
hours, and (3) a Glasgow Coma Scale score of 13 or greater quantifying level of 
consciousness (Harrington, et al., 1993).   PTSD as defined in the DSM-IV Text Revised, 
is an anxiety disorder that encompasses four major criteria: witnessing an event that is 
threatening to one‟s well-being, symptoms of reexperiencing, avoidance of thoughts, and 
increased arousal.  One word to describe the more complex type of illnesses military 
doctors are treating is polytrauma.   
Polytrauma “encompasses injuries to more than one physical region or organ 
system, one of which may be life threatening, and which results in physical, cognitive, 
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psychological, or psychosocial impairments and functional disability” (Belanger, 
Uomoto, & Vanderploeg, 2009).  These types of injuries are referred to as “blast injuries” 
and are a frequent occurrence in Iraq and Afghanistan.   
The major issue is that the comorbid symptoms lend themselves to misdiagnosis 
of mTBI with PTSD.  For this reason, it is difficult to determine which diagnosis is 
correct, or whether both co-occur.  In the case of mild symptoms, neither condition may 
be diagnosed.  There are costs associated with all of these situations.  Failing to treat a 
condition can lead to long-term increases in care as well as loss of function.  Treating a 
condition that is not present is needlessly expensive and can directly conflict with a more 
appropriate treatment as, for example, if drugs given to relieve anxiety in PTSD 
aggravate an undiagnosed brain injury.   
Currently there is no specific tool to determine if a soldier has mTBI or PTSD.  
Most of the tools used to diagnose soldiers are questionnaires, which used alone may lead 
to misdiagnosis.  Some soldiers lie on these types of questionnaires in order to prevent 
delaying their journey home (Tanielian & Jaycox, 2008).  There are also follow up 
questionnaires a few months after deployment that may help determine if a soldier 
sustained a mTBI or has developed PTSD.  While these methods are useful, there are 
soldiers who do not seek medical treatment.  We believe the ones that do not seek 
medical treatment account for a majority of the total medical costs seen today.  In order 
to shed light on the costs of misdiagnosis, we separate out the PTSD and mTBI costs 
from the other medical costs.  We expect to find a difference in cost between diagnosing 
PTSD, mTBI and a combination of both illnesses.   
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Purpose of This Study 
 The purpose of this research is to evaluate the costs of misdiagnosing mTBI and 
PTSD.  The object of this effort is a cost model which will outline the different costs for 
treating PTSD and mTBI as well as the costs of treating PTSD with mTBI.  Our goal is 
for the cost model to enable better decision making regarding treatments when the 
presentation of symptoms is ambiguous. In order to assess the costs of misdiagnosing 
PTSD and mTBI, we answer the questions outlined in the following section.    
Research Question 
What are the near-term monetary costs of treating active duty personnel with 
mTBI and PTSD? 
Hypothesis 
Failing to diagnose and treat mTBIs increases lifetime monetary costs over the 
money saved by treating a false positive mTBI. 
Implications 
This research sheds light on the costs of misdiagnosing mTBIs and has the 
potential to bring about change.  The cost model could have potential service-wide and 
worldwide implications.  Doctors throughout the service and civilian sector may not 
realize the costs associated with misdiagnosing a patient.  By characterizing the typical 
treatment decisions made as a result of diagnostic choices, the model will show the near 
and long term costs linked with the doctor‟s decisions.  A new understanding of the cost 
of misdiagnosis may reduce long-term medical costs and, as a result, may increase the 
percentage of proper diagnoses.   
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Preview 
Discussion will begin with existing literature on PTSD and mTBI and the 
methods used to diagnose a patient.  We will analyze 2007 and 2008 medical cost data 
and determine the costs for PTSD and mTBI.  We will also discuss the applicability for 
service and worldwide use, as well as propose recommendations to facilitate analyzing 
misdiagnosis costs in the future. 
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Chapter II:  Literature Review 
 
 In this chapter, we provide the reader with a general overview of PTSD and 
mTBI.  We discuss the critical components of the misdiagnosis of PTSD with mTBI.  We 
also offer background and general discussion on previous research and how the previous 
research applies to our current research.  
TBI Overview 
There are different types of brain injuries that can occur.  A penetrating injury 
occurs when an object pierces the skull and enters brain tissue.  A closed head injury 
occurs when the head hits an object but the object does not break through the skull, 
resulting in rapid acceleration and deceleration of the brain.  A blast exposure can also 
cause a non-penetrating injury due to the blast wave transmitting through the brain 
(Tanielian & Jaycox, 2008). 
There are also different phases of blasts.  Due to the changes in atmospheric 
pressure; “a high-explosive detonation results from the nearly instantaneous conversion 
of a solid or liquid into gasses.  Momentarily, these gasses occupy the same volume as 
the parent solid or liquid and thus they are under extremely high pressure.  The gasses 
expand rapidly, causing compression in the surrounding air, forming a pulse of pressure” 
such as in Figure 1 (Taber, Warden, & Hurley, 2006).  The pressure will drop as the 
gasses continue to expand which creates a relative vacuum (blast under pressure, negative 
phase of the blast wave).  The blast creates a massive swing in the pressures placed on the 
body which results in both shear and stress waves.  These waves create forces that affect 
17 
 
bodily organs and tissues and can cause secondary and tertiary blast injuries.  A 
secondary blast injury occurs when objects impact a person, which is also known as 
ballistic trauma, and tertiary blast injury occurs when a person is thrown into solid 
objects. 
Figure 1 explains the sequence of changes in atmospheric pressure following an 
explosion which make up the blast wave.  Prior to the explosion (1), pressure is normal.  
With the passage of the shock front (2), the blast forces are maximal and the wind flows 
away from the explosion (2, arrow).  This is followed by a drop in atmospheric pressure 
to below normal (3), resulting in the reversusd blast wind (3, arrow).  Atmospheric 
pressure returns to normal after the blast wave subsides (4) (Taber, Warden, & Hurley, 
2006). 
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Figure 1: Effects of a Blast Wave 
Reprinted with permission from the Journal of Neuropsychiatry and Clinical 
Neurosciences, (Copyright 2006).  American Psychiatric Publishing, Inc. 
The environment surrounding the situation also factors into a service member‟s 
injuries.  For example, explosions near or within hard solid surfaces become amplified 
two to nine times because of shock-wave reflection (Rice & Heck, 2000).  Moreover, 
victims positioned between the blast and buildings often suffer 2–3 times the degree of 
injury of a person in an open space. Indeed, people exposed to explosion rarely 
experience the idealized pressure-wave form, known as the Friedländer wave.  Even in 
open-field conditions, the blast wave reflects from the ground, generating reflective 
waves that interact with the primary wave and thus changing its characteristics.  In a 
closed environment (such as a building, an urban setting, or a vehicle), the blast wave 
interacts with surrounding structures and creates multiple wave reflections, which, 
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interacting with the primary wave and between each other, generate a complex wave ( 
(Mainiero & Sapko, 1996); (Ben-Dor, Igra, & Elperin, 2001) ). 
Due to blast effects, doctors use the Glasgow Coma Scale to measure the severity 
of the TBI, which assesses a patient‟s eye opening, motor, and verbal response.  Two 
other measures for TBI severity are the length of loss of consciousness and length of 
post-traumatic amnesia (Tanielian & Jaycox, 2008).  The Glasgow Coma Scale is a 1-15 
scale with one being the most severe and fifteen being the least severe.  The TBI 
definition proposed by the American Congress of Rehabilitation Medicine includes (1) 
associated diminished or altered state of or loss of consciousness (LOC), i.e., interruption 
of awareness of oneself and surroundings for less than 30 minutes; (2) posttraumatic 
amnesia (PTA), i.e., memory disruption following injury (not able to store or retrieve 
new information) for less than 24 hours, and (3) a Glasgow Coma Scale score of 13 or 
greater quantifying level of consciousness (Harrington, et al., 1993).   
Moderate to severe TBIs are evident in neuroimaging data and doctors have 
observed and documented periods of loss of consciousness (LOC).  However, there is no 
single diagnosis tool for TBI that is sensitive to all levels of severity and chronicity.  By 
definition, patients with mild TBI have normal findings on clinical neuroimaging.  In the 
absence of abnormal neuroimaging, medically observed and documented loss or 
alteration of consciousness is the most commonly used criterion measure for the presence 
of brain injury (Belanger, Uomoto, & Vanderploeg, 2009).  Due to the lack of physical 
evidence, doctors may overlook mTBIs.   
There are many different reasons a soldier could report an alteration in 
consciousness, such as an adrenaline rush or emotional issues, which makes proper 
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diagnosis even more difficult.  An alteration in consciousness may not be a LOC.  For 
example, a soldier could have had an alteration of consciousness and during this time 
new memories may not have been consolidated because of posttraumatic disorientation.  
Also, symptoms may be due to a residual postconcussion syndrome (PCS) related to a 
mild TBI, but false positive errors would result if current symptoms are due to other 
postdeployment conditions such as PTSD, depression, substance abuse, chronic sleep 
disorder, and/or chronic pain (Belanger, Uomoto, & Vanderploeg, 2009). 
 There are many different symptoms associated with mTBI as seen in Table 1. 
Table 1: Mild Traumatic Brain Injury Symptoms 
attention loss of motor skills dizziness ringing in the ears 
concentration balance depression Vomiting 
problems learning 
new things seizures anxiety Guilt 
poor memory mental fatigue sleep problems Nausea 
explosive temper reading problems irritability inconsideration 
Slowed reasoning 
feelings of 
helplessness drowsiness headache 
withdrawal from 
social activities writing problems anger 
speed of 
information 
processing 
self-awareness poor judgment blurred vision confusion 
The Rand Corporation conducted a study on soldiers who reported injuries with a 
LOC and/or altered mental status during their deployment.  From this study, Rand 
reported that 19.5% of soldiers sustained a probable mTBI. (Tanielian & Jaycox, 2008).  
Hoge et al reported a similar finding of 15% of probable mTBI during a deployment 
(Hoge, Castro, Messer, McGurk, Cotting, & Koffman, 2004).  Even though these 
findings are high, there are still solders that may not know they sustained mTBI and the 
injury goes unreported. 
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PTSD Overview 
 It is likely that an individual will experience at least one traumatic event in their 
lifetime.  People react to traumatic situations differently and typically, most people are 
able to overcome the experience and move on with their lives. However, some may suffer 
for years.  According to a study conducted by Dr. Breslau, a high proportion of persons 
with PTSD (approximately 82%) meet Diagnostic and Statistical Manual Fourth Edition 
(DSM-IV) criteria of having PTSD symptoms for at least three months.  In addition, 
approximately 74% continue to have symptoms for six months or more (Breslau, 2001).  
Military rates of PTSD are different from civilian rates because of the nature of a military 
profession.  During combat, military members can face numerous traumatic events that 
can prolong their recovery time.   
Surveys of military personnel returning from deployments to Iraq and 
Afghanistan have shown that the prevalence rates of PTSD range from 8% to 16% 
(Tanielian & Jaycox, 2008).  However, some soldiers do not seek medical treatment for 
fear of reprisal, which can skew the statistics.  PTSD in essence develops when 
symptoms fail to resolve after some psychological trauma, which is why prompt 
treatment is critical to helping patients recover faster. 
PTSD as defined in the DSM-IV Text Revised, is an anxiety disorder 
encompassing four major criteria: 
1. Exposure to or witnessing an event that is threatening to one‟s well-being and 
responding with intense fear, helplessness, or horror 
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2. Symptoms of reexperiencing, such as recurrent and intrusive memories, 
nightmares, a sense of reliving the trauma, or psychological and physiological 
distress when reminded of aspects of the trauma 
3. Avoidance of thoughts, feelings, or reminders of the trauma, and the inability to 
recall parts of the trauma, withdrawal, and emotional numbing 
4. Arousal increases, as manifested in sleep disturbance, irritability, difficulty 
concentrating, hypervigilance, or exaggerated startle response 
In addition to the four criteria, there are many other symptoms associated with PTSD 
as seen in Table 2. 
Table 2: PTSD Symptoms 
intrusive sensations 
and cognitions exhaustion 
emotional numbing insomnia 
avoidance headaches 
physiological 
hyperarousal startle response 
memory  disturbances 
reduced relational 
intimacy 
attention noise sensitivity 
concentration fatigue 
irritability 
increased sensitivity to 
light 
impaired decision 
making anxiety 
 There are many different risk factors involved when a person has PTSD.  
Assessment of suicidal risk is important because there is evidence of a positive 
association between the number of previous traumatic events and the likelihood of a 
suicide attempt (Friedman, 2006).  Two different studies using a National Comorbidity 
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Survey indicate, “persons with lifetime PTSD were significantly more likely to report 
having thought about killing themselves and to have made an attempt, even after 
accounting for a variety of potential sociodemographic and mental health confounding 
factors (Tanielian & Jaycox, 2008) (Kessler, Borges, and Walters, 1999; Sareen et al., 
2005).  The individual with PTSD may be a threat to others if they become violent or 
engage in risky behaviors.  Some individuals may turn to drugs and/or alcohol to cope 
with the traumatic experience.  Everyone differs in his or her reaction to a traumatic event 
and some may be able to cope better than others can.  It is important that these 
individuals receive social support in order to help with the healing process. 
Comorbid Symptoms 
 Comorbid symptoms create challenges when evaluating patients.  Many factors 
tend to co-occur with mild TBI and can complicate both assessment and treatment.  
These factors include preexisting stress and social difficulties, learning disabilities, 
history or previous neurologic or psychiatric disorders, and preinjury alcohol or drug 
abuse (Belanger, Uomoto, & Vanderploeg, 2009).  The RAND study reported a high rate 
(33%) of co-occurrence between a history of mTBI, PTSD, and depression. 
In practice, the clinical distinction between PTSD and mTBI relies on the 
predominant symptoms.  When a patient has more organic symptoms such as headache, 
dizziness, visual complaints, hearing loss, balance problems, and cognitive disturbance, 
the patient is thought to have post-concussion syndrome.  However, PTSD typically 
manifests when the predominant features are symptoms such as nightmares, 
hyperarousal, avoidance, and reexperiencing phenomena (Elder & Cristian, 2009).  
Consequently, the time interval between the event and the assessment is critical in the 
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diagnosis of PTSD and/or mTBI.  However, some individuals who experience a traumatic 
event may not report their injury right away and it could even be years before a doctor 
sees a soldier.  For properly diagnosing mTBI, it is extremely important to document the 
symptoms that occur at the time of the event (i.e. LOC, altered consciousness).  There is 
potential for a significant gap in time from incident to assessment and doctors may never 
know if there was a true LOC or just an altered state of consciousness, which makes 
proper diagnoses difficult.  While most mTBIs resolve on their own, 10-15% of persons 
with mTBI develop postconcussive symptoms (PCS) (McCrea, 2008).  If PCS symptoms 
are not treated, they could become Persistent Postconcussive Symptoms (PPCS) as shown 
in Figure 2.  We modeled Figure 2 after a figure in the article Exploring the Convergence 
of PTSD and mTBI. 
 
Figure 2: Interface of PTSD and Persistent Postconcussive Symptoms (PPCS) 
following MTBI 
 
PPCS
-Headache
-Sensitivity to 
light (and sound)
-Memory deficit
-Dizziness
PTSD  
-Reexperiencing 
symptoms
-Shame
-Guilt
-Depression/ 
anxiety                 
-Insomnia            
-Irritability/anger 
-Trouble 
concentrating       
-Fatigue     
-Hyperarousal     
-Avoidance 
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Schneiderman et al conducted a study and found that about 12% of more than 
2,200 veterans who returned from Iraq and Afghanistan reported a history consistent with 
mTBI, and 11% screened positive for PTSD (Schneiderman, Braver, & Kang).  It is 
interesting that the risk of PTSD almost doubled due to combat related mTBI.  The 
strongest factor associated with persistent postconcussive symptoms was PTSD.  Even 
after removing the overlapping symptoms in Figure 2 from the PTSD score, the 
association between postconcussive and PTSD symptoms remained strong (Stein & 
McAllister, 2009). 
Vanderploeg et al conducted a study with Vietnam-era veterans to determine the 
associations of various symptoms and psychiatric diagnosis with a remote history of 
mTBI and a current diagnosis of PTSD.  Vanderploeg et al found that sixteen years after 
combat 68.6% of the Motor Vehicle Crash (MVC) injury control group no longer met 
criteria for PTSD (significant at p < .05).  In contrast, in the mTBI group, only 47.5% 
resolved (Vanderploeg, Belanger, & Curtiss, 2009).  Vanderploeg‟s article demonstrates 
that mTBI adversely affects the potential recovery of PTSD.  With early intervention, 
these statistics can improve. 
Hoge et al reported that 43.9% of soldiers who had symptoms associated with 
LOC also met the criteria for PTSD.  However, after adjusting for PTSD and depression, 
mTBI was no longer significantly associated with PCS symptoms (except headache) and 
physical health outcomes.  These authors suggest that the high rates of physical health 
problems reported by soldiers with mTBI are mediated largely or entirely by PTSD or 
depression rather than the mTBI (Belanger, Uomoto, & Vanderploeg, 2009).  Belanger et 
al believe that in the OEF/OIF population, even poor performance on neuropsychological 
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tests may be more associated with deployment-related stress or PTSD than with mTBI.  
Some military doctors believe that mTBI is simply a concussion and doctors need to treat 
it as such because the real health issue is either PTSD or depression.  Misattribution of 
symptoms to a residual TBI when such symptoms are secondary to stress, chronic sleep 
deprivation, PTSD or other mental health condition, for example, could iatrogenically 
reinforce the misconception that these symptoms are permanent (Belanger, Uomoto, & 
Vanderploeg, 2009).  Doctors such as Richard Bryant believe that mTBI has been 
mistaken for PTSD or depression and that the impairment observed in the aftermath of 
mild traumatic brain injury may be incorrectly attributed to psychological distress, rather 
than neurologic insult (Bryant, 2008).  Bryant also mentioned a study that found that 
psychological factors play a significant role in postconcussive symptoms and these 
symptoms occur at similar rates in persons with mTBI and those with no TBI. 
Mild TBI may not always be PTSD or depression though, which leads to another 
idea of mTBIs and the significance of properly diagnosing them.  Dismissing the mTBIs 
and treating patients for PTSD can create a magnitude of problems when treating 
patients.  Patients who have mTBIs may develop psychological disorders such as PTSD 
or depression in the future, which leads to two theories.  The first theory is that the 
combination of the comorbid conditions such as PTSD and depression cause the 
persistent symptoms of the mTBI.  The second is that the mTBI was not properly treated 
which led to other problems such as PTSD.   Either way, the delayed onset of symptoms 
may cause problems in diagnosing both PTSD and mTBI. 
The relationship between PTSD and TBI is interesting to military doctors around 
the world.  TBI is a classic example of an organic brain disease and PTSD is a 
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psychologically based reaction to a stressor that was not associated with physical injury.  
Some medics suggest that TBIs protect patients from PTSD because the blackout period 
prevents the psychological trauma from occurring.  However, because service personnel 
in a war zone inevitably have exposure to PTSD stressors independent of TBI events, the 
coexistence of the two disorders is easy to imagine (Elder & Cristian, 2009).   
The distinction between these two disorders affects both treatment strategies and 
patient education.  The PTSD reaction is an abnormally sustained stress response.  PTSD 
treatment focuses on normalization of these stress reactions through psychologically-
based therapies as well as pharmacologically-based treatments.  On the other hand, the 
TBI treatment framework is more of an organic model.  This model assumes that 
structural brain alterations have occurred and that recovery depends on neurological 
factors, with treatment focused on improving attention and concentration with agents 
such as psychostimulants or improving compensatory strategies through 
cognitive/behavioral therapies (Elder & Cristian, 2009). 
Another possibility regarding the interface of PTSD and TBI is that TBI may 
influence the development of PTSD.  Mild TBI‟s can impair the cognitive abilities that 
are necessary to manage the repercussions of a psychological trauma.  Hoge et al 
speculates that TBI‟s might impair these cognitive abilities by damaging the brain 
structures that are thought to be critical in PTSD (Elder & Cristian, 2009) (Hoge, 
Thomas, Cox, Engel, & Castro, 2008).  Figure 3 shows how the presence of TBI can 
influence the presence of PTSD.  Schneiderman et al and Hoge et al both conducted 
studies in 2008 of military personnel post-deployment.  These studies show the linkage 
between combat-related TBI and an increased incidence of PTSD.  Hoge‟s findings were 
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statistically significant in that the 43.9% of soldiers who lost consciousness also met the 
criteria for PTSD (p-value of .001) (Hoge, Thomas, Cox, Engel, & Castro, 2008). 
 
Figure 3: Association Between PTSD and TBI 
Reprinted with permission from the Journal of Neuropsychiatry and Clinical 
Neurosciences, (Copyright 2006).  American Psychiatric Publishing, Inc 
 In the war zone soldiers are taught to be hypervigilent.  The amygdala, a complex 
structure involved in a wide range of normal behavioral functions and psychiatric 
conditions, is responsible for increased reflexes and thus during combat soldiers have a 
hyperactive amygdala (LeDoux, 2008).  When their tour is over, the soldiers return home 
and are to shut off their hypervigilance, combat ready state of mind.  PTSD severely 
disrupts the normal restraint on the amygdala and soldiers are unable to lead their lives 
the way they did before they deployed (Friedman, 2006). 
PTSD may relate to the type of brain injury sustained.  Certain areas of the brain 
are more susceptible to damage from a blast. This is particularly true for cortical areas 
vulnerable to blast injury transfer through the skull or the „soft-tissue portals‟ of the skull. 
The role of these cortex areas is to inhibit structures just below the cortex and to integrate 
information.  Damage to susceptible cortical areas, in particular to the prefrontal and 
temporal cortices, can lead to lack of restraint of the brain structures that regulate fear and 
anxiety responses (Wrathall et al., 2009). 
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There have been numerous functional imaging studies conducted in order to 
determine what areas of the brain PTSD, TBI, and both affect.  When a patient has PTSD, 
the amygdala becomes overactive and the cortical regions become underactive.  With 
these data in mind, it should be possible to make neuroanatomically specific hypothesis 
about the risk of PTSD depending on the location of brain lesions (Stein & McAllister, 
2009).  This is just one way to help decode the comorbidities involved with mTBIs and 
PTSD, but it may not be feasible on a large scale.  It would be difficult and costly to 
screen every soldier returning from Iraq and Afghanistan. 
Screening 
The three common methods to identify “caseness” (i.e., who has a disease or 
disorder, referred to as cases, and who does not) in psychiatric epidemiology are: 
diagnostic codes from case registries among individuals in treatment contact (i.e., 
receiving some type of medical care); screening tools that identify persons with probable 
disorders; and diagnostic interviews that assign actual diagnoses based on criteria set 
forth in the Diagnostic and Statistical Manual of Mental Disorders (DSM) [American 
Psychiatric Association, 2000] or International Classification of Diseases (ICD) 
(Tanielian & Jaycox, 2008).  Each tool has its benefits but almost all screening tools have 
a tradeoff between sensitivity and specificity, which determine the tools‟ validity.  The 
sensitivity is the proportion of persons with a given condition correctly identified by the 
screening tool as having the condition and the specificity is the proportion of persons 
without a condition correctly identified by the screening tool as not having the condition.  
The tools for detecting a mTBI and PTSD can either identify all possible cases or only 
identify true cases or something in between the two (Tanielian & Jaycox, 2008).  The 
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researcher asks experts what their goal is when detecting mTBI and PTSD and creates a 
tool based on the experts needs. 
Questionnaires 
The Department of Defense and the Department of Veterans Affairs have 
implemented new screening measures in light of the recent attention to the “signature 
wounds of war.”  The Air Force conducts the Periodic Health Assessment (PHA) once a 
year to ensure Airmen are physically and mentally ready for combat.  Before a member 
can deploy they must complete a Pre-Deployment Health Assessment (PDHA) within 
sixty days prior to deployment.  This assessment identifies any health concerns that need 
addressed before the member‟s deployment.  The servicemember must complete the 
PDHA within thirty days before and after deployment.  The PDHA identifies any mental 
or physical health concerns associated with deployments as well as deployment-related 
occupational or environmental exposures.  In 2005, the Post-Deployment Health Re-
Assessment (PDHRA) was initiated to focus on servicemembers‟ health concerns that 
emerge over time after their return from deployment.  The military administers the 
PDHRA ninety to one hundred and eighty days after the members return from 
deployment (GAO, 2008).  Effective June 1, 2007 the DoD added TBI screening 
questions to the PHA, PDHA and the PDHRA. 
 The questions added to the PDHA are cognitive assessment questions that help 
determine if there is a problem with abilities such as memory and reaction time.  The 
sequence of questions specifically assesses (a) events that may have increased the risk of 
a TBI, (b) immediate symptoms following the event, (c) new or worsening symptoms 
following the event, and (d) current symptoms. If there is a positive response to any 
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question in the first series, the servicemember completes the second and third series; if 
there is a positive response to any question in the third series, the servicemember 
completes the fourth series about current symptoms. The PDHA directs the health care 
provider to refer the servicemember based on the servicemember‟s current symptoms 
(GAO, 2008).  See Figure 4 for the screening questions for the PDHA; the PHA 
questions are similar but do not reflect the servicemember‟s deployment. 
 
Figure 4: TBI Screening Questions on the PDHA 
Source: GAO Analysis of DoD Screening Questions 
 
The Warrior Administered Retrospective Casualty Assessment Tool (WARCAT) 
is a relatively new tool developed at Fort Carson, Colorado.  The WARCAT is a 
questionnaire that enables soldiers to indicate whether they were injured from 
mechanisms commonly associated with TBI while deployed, whether any injuries 
resulted in an altered mental status indicative of TBI, and/or whether specific somatic and 
neuropsychiatric symptoms commonly associated with mild TBI occurred after the injury 
(immediately postinjury and/or postdeployment) (Terrio, et al., 2009). 
The Defense and Veterans Brain Injury Center (DVBIC) created a three-question 
TBI screening tool that the military is using to screen returning OEF/OIF servicemembers 
for TBI.  The Brief Traumatic Brain Injury Screen (BTBIS) has demonstrated a positive 
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value for predicting TBI in the OEF/OIF population (Schwab, Baker, Ivins, Sluss-Tiller, 
Lux, & Warden, 2006).  However, this tool has yet to be validated against actual clinical 
diagnoses.  While the screening is of value, simply meeting the criteria does not require 
current TBI related injuries and it may not assess ongoing trauma related impairments. 
Due to the increase rate of missed cases, DVBIC developed a tool for determining 
cognitive deficits due to mTBI.  The main goals of the Military Acute Concussion 
Evaluation (MACE) are to confirm the diagnosis of mTBI, and to provide further 
assessment data by using the Standard Assessment of Concussion to record 
neurocognitive deficits (McCrea et al., 1997).  Medics and/or corpsmen can easily 
administer MACE within five minutes and the evaluation consists of thirteen items (8 
history items and 5 examination items) (Elder & Cristian, 2009).  The history items are to 
capture the details of the incident and enable the medical staff to provide a score of 1-30.  
Scores below 25 may be indicative of cognitive impairment (DVBIC). 
The military uses the 17-item National Center for PTSD Checklist, which is an 
instrument that contains seventeen symptom items keyed directly to the DSM-IV.  
Symptoms receive a score according to the DSM-IV definition for PTSD.  A patient will 
test positive if they meet the DSM-IV criteria, which includes one intrusion symptom, 
three avoidance symptoms, and two hyperarousal symptoms.  However, there are 
problems with the screening tools we use to assess both PTSD and mTBI. 
Problems with Screening Tools 
 Table 3 provides a visual overview of the screening tools and the problems 
associated with the tools. 
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Table 3: Overview of mTBIand PTSD Screening Tools 
Screening Tool Target Group Effectiveness Who is  missed 
PHA/PDHA/ 
PDHRA 
 
All members of the military 
receive PHA annually, 
PDHA before and after 
deployment, and PDHRA 
after deployment 
As of 2007, less than 0.5% of 
active duty AF members who have 
deployed receive a diagnosis of 
PTSD and approximately 1% 
screen positive for TBI 
Some Reserve and 
Guard members 
WARCAT 
Not a DoD wide program.  
Only some Army personnel 
receive this assessment 
It is under a study protocol 
evaluation to see if it can be 
validated 
Most military 
personnel 
BTBIS 
Soldiers returning from Iraq 
and Afghanistan Not validated 
Soldiers who 
returned before 
2006 
MACE 
In theater  
 
Validation for In‐Theater 
Evaluation of Combat‐Related 
Traumatic Brain Injury is pending 
IRB approval 
Medic and/or 
corpsmen discretion 
 
PTSD 17-item 
checklist 
 
Self report 
 
 
According to Weathers et al the 
checklist has good sensitivity (.82) 
and specificity
 
(.83) in correctly 
identifying subjects‟ PTSD 
diagnostic
 
status when a score of 
50 or more is used as a cut-point* 
Soldiers who do not 
seek medical 
attention for PTSD 
like symptoms 
 
 Absence of evidence is not proof of absence, which hinders the effectiveness of 
any screening method.  However, the screening tools the military uses are not perfect.  
Colonel Hoge of the Walter Reed Army Institute of Research presented a briefing in 
February 2009 on PTSD Screening Among Service Members Returning from Iraq and 
Afghanistan.  He discussed the 17-item PTSD checklist (PCL) and the Post-deployment 
Health Assessments utilizing PC-PTSD screen and noted the utilization data are not 
reliable for PTSD surveillance.  He found that different cutpoint numbers for the PCL 
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resulted in different sensitivity ranges.  The higher the cutpoint, the higher percentage of 
people who screen positive will actually have PTSD as seen in Figure 5.  The lower 
cutpoints use many resources for unnecessary evaluations; however, they make sense for 
clinical screening.  Colonel Hoge stated, “the higher cutpoints are required for 
surveillance population prevalence estimates, and for screening on a population-level” 
(Hoge C. W., PTSD Screening Among Service Members Returning from Iraq and 
Afghanistan, 2009). 
 
 
Figure 5: Estimated Prevalence of PTSD versus True Prevalence 
Source: Col Hoge’s PTSD Screening Among Service Members 
Returning from Iraq and Afghanistan Briefing 
 
Screening tools are inevitably wrong because researchers do not have the time to 
measure the entire population.  Researchers administer these tools to subsamples, 
Cutpoint 30,32 
 
Cutpoint 38,40 
Cutpoint 44,45 
Cutpoint 48,50 
Cutpoint >54 
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providing us with inaccurate estimates of prevalence.  However, we do not have a better, 
cost effective option to identify individuals who might have a medical condition and need 
treatment.  There is an option that may improve the prevalence rates and that option is 
interviews. 
Interviews 
Another method of screening is structured interviews.  Frequently, the clinician‟s 
best option is to ask the patient to provide a detailed account of the event, thereby 
assessing for gaps in memory for the event, or asking the patient what he was informed 
about his or her behavior or mental state by military colleagues who observed him or her 
at the site (Belanger, Uomoto, & Vanderploeg, 2009).  Interviews are beneficial because 
they allow doctors to gather more information than simply a yes or no answer on a 
questionnaire.  With this additional information, doctors can make a better assessment of 
the symptoms and severity of the injury or disorder. 
Treatments 
There is very little research conducted regarding the treatment of comorbid 
conditions.  However, the Rand study briefly covers the treatment of co-morbid 
symptoms and they determined that providers who assess patients with mTBI and PTSD 
symptoms must determine the proper sequence of treatment to implement (Belanger, 
Uomoto, & Vanderploeg, 2009).  For example, an OEF/OIF veteran with severe 
symptoms of PTSD may not be ready to participate in comprehensive post-acute 
polytrauma/TBI rehabilitation services and hence may first benefit from stabilization of 
emotional problems secondary to PTSD or other mental health conditions (Tanielian & 
Jaycox, 2008).  Treatment for PTSD may require modification given the potential 
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interference of TBI-related cognitive compromise, especially in the immediate aftermath 
of a concussion (Nelson, Yoash-Gantz, Pickett, & Campbell, 2009). 
“A frank neurologic insult such as TBI may exacerbate PTSD symptoms because of a 
greater inability to self-regulate and inhibit behavioral responses” (Nelson, Yoash-Gantz, 
Pickett, & Campbell, 2009).  Nevertheless, it is important to note that mTBI symptoms 
are not always chronic and with the right treatment, a patient may not develop PTSD.  
The majority of cognitive symptoms associated with mTBI disappear after one month of 
injury.  Nevertheless, the military must be able to meet the needs of the minority of 
patients with prolonged mTBI symptoms because recovery is a gradual process that 
occurs for at least 18-36 months as the brain recovers and regenerates.   
Cost 
 The Invisible Wounds of War RAND Report studied the treatment and 
rehabilitation costs for PTSD, depression, and TBI as well as the medical costs associated 
with suicide attempts and completions, the value of lives lost to suicide, the value of lives 
lost to TBI and the lost productivity stemming from PTSD, depression and TBI.  
RAND‟s goal was to project 2-year post-deployment costs associated with PTSD and 
depression.  Their goal for TBI was to calculate the total costs associated with TBI in 
2005.  RAND choose a microsimulation approach for determining the costs for PTSD 
and depression with three different treatment pathways: usual care, evidence-based care, 
and no care.  On average, individuals receiving evidence-based treatment have a higher 
probability of remission than individuals receiving usual care, who in turn have a higher 
probability of remission than those receiving no care (Tanielian & Jaycox, 2008).  RAND 
predicted the baseline two-year costs per case of on E-5 with PTSD and receiving no care 
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to be $11,986.  With usual care, the cost increased to $13,935 but with evidence-based 
care, the cost dropped to $7,933 FY08 dollars.  With microsimulation models, the model 
results can be extremely dependent on the constraints used to assign event probabilities.  
Thus, any deviation from these constraints can cause the results to be misleading. 
 RAND calculated TBI costs based on civilian populations because they were 
unable to collect any TBI data from the military or the VA.  RAND chose three 
categories of treatment to estimate the cost of TBI: acute hospital care, inpatient 
rehabilitation, and outpatient rehabilitation.  They predicted high and low costs.  The high 
cost for mTBI acute hospital care was $21,346 and the low was $15,144 (FY05 dollars).  
The inpatient rehabilitation costs for mTBI was not applicable while outpatient costs 
were $1,487 and $618 for high and low, respectively.  Since RAND could not obtain 
military cost information, these costs cannot directly correlate to the military population. 
In FY 1992, Ommaya et al conducted a review to identify head injury admissions 
using incidence rates, case fatality rates, causes of head injuries, and direct cost for 
hospital admissions.  Ommaya et al examined hospital discharge records and private 
facilities that received reimbursement from CHAMPUS now known as TRICARE.  They 
used the average cost per occupied bed day to determine the expenses to include the 
clinic proportion of total facility cost, including construction, facility expenses, 
professional and staff wages, equipment, and supplies.  The authors then assigned costs to 
each patient by determining the length of stay in each clinic and intensive care unit and 
any days spent in civilian hospitals.  Ommaya et al found 5,568 hospitalized cases of 
noncombat head injury in the military medical system and a total cost of $43 million in 
FY02 dollars.  The authors concluded that there is a need to develop prospective payment 
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mechanisms for rehabilitations and injury rehabilitation problems (Ommaya, Ommaya, 
Dannenberg, & Salazar, 1996). 
Now that we have examined the previous research, we can develop a 
methodology that will answer our research questions and analyze PTSD and mTBI cost 
data. 
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Chapter III:  Data Collection and Methodology 
 
In this chapter, we describe the data and how we propose to answer each of the 
research questions outlined in Chapter I.  Our goal is to take raw medical data and 
separate out the cost of treating mTBI and PTSD to see how much of the total medical 
costs come from mTBI and PTSD.  In order to do this, we must first explain the variables 
and where we acquired the data for each of the variables.  Then, we discuss the 
shortcomings of the data.  Lastly, we discuss the methods that we use in Chapter IV to 
analyze and interpret the results. 
Data Sources and Variables 
The search engine ProQuest enabled us to explore the Nursing and Allied Health 
Source, the Pharmaceutical New Index, the ProQuest Health and Medical Complete, the 
Psychology Journals, and the ProQuest Medical Library database.  We also utilized the 
search engine PubMed and if articles were not available due to limited access, Dr. Stuart 
Hoffman sent them to us.  In brief, the overall approach used was to define mTBI, PTSD, 
the behavioral symptoms of each individually and combined, and the therapies for each 
individually and combined.  We used the terms TBI, PTSD, misdiagnosing TBI and 
PTSD, and costs of misdiagnosing TBI and PTSD to generate English language articles. 
Dependent Variables 
Defining the dependent variables is critical to our research because there are many 
different illness codes used when determining the medical costs.  Table 4 shows the main 
codes we will use as our dependent variables. 
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Table 4: PTSD and mTBI ICD-9 Codes 
Illness ICD-9 code 
PTSD  309.81 
Skull fracture  
800.0, 800.01, 800.02, 800.49, 801.0, 801.01, 801.02, 801.06, 
801.46, 801.96, 803.0, 803.01, 803.02, 803.09, 803.5, 804.0, 
804.5 
Concussion  
850.0, 850.11, 850.5, 850.9, 851.0, 851.01, 851.02, 851.05, 
851.09, 851.81, 851.86, 852.0, 852.01, 852.06, 852.09, 853.00, 
853.01 
Intracranial injury of 
other and unspecified 
nature  
854.0, 854.01, 854.02, 854.03, 854.06, 854.09, 860.0, 860.4, 
920, 958.4 
Head injury unspecified 959.01, 959.09 
  Independent Variable 
Our research explores the predictive power of average cost variables, due to 
multiple occurrences of specific medical diagnoses, in an attempt to predict the cost of 
misdiagnosing PTSD and mTBI. 
Methodology 
Mrs. Deirdre Baker, Project Manager, Medical Expense and Performance 
Reporting System (MEPRS), scrubbed medical data for the costs associated with the 
codes listed in Table 4.  MEPRS is a worldwide Tri-Service system that aggregates 
uniform medical and dental facility manpower, expense, and workload data.  The 
information is from the MHS Data Mart (M2).  The military calculates financial data 
using a Patient Level Cost Accounting methodology and the data are only the gross 
financial data (by clinic or inpatient specialty).  In order to allocate costs across 
individual patients, the military establishes rates and applies the relative value weights 
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(RVUs) or Diagnostic Related Group (DRG) weights to each patient.  The Centers for 
Medicare and Medicaid Services (CMS) maintain a list of relative value weights (RVUs) 
for inpatient hospital care.  These RVUs, known as the Diagnostic Related Group (DRG) 
weight, based on the primary diagnosis when the patient enters the hospital.  The DRG 
relative value weight is located on the CMS web site (Average Cost Estimates, 2008).   
The cost data we received are not broken out by a specific individual or hospital; 
it is by the ordered diagnoses.  We have eight and four diagnoses for the inpatient and 
ambulatory data, respectively.  Table 5 shows the different medical costs for a sample set 
of data for a given fiscal year (FY) and a given month (FM 1-12) with four different 
diagnoses (D1-D4). 
Table 5: Sample Set of Data 
 
FY FM D 1 D 2 D 3 D 4 
Clin 
Salary 
Lab Other 
Other 
An-
cillary 
Other 
Salary 
Pharm Rad 
Full 
Cost 
 
07 10 30981 3149 79998 V7109 $73.14 $3.10 $125.56 $0.20 $102.37 $14.66 $2.44 $321.47 
 
07 10 30981 3149 V629 V119 $48.58 $3.10 $125.56 $0.20 $102.37 $14.66 $2.44 $296.91 
 
08 1 30981 30742 V7109 V609 $74.98 $8.23 $110.83 $0.53 $244.94 $6.87 $1.93 $448.31 
 
08 1 30981 30742 V7109 V629 $36.44 $8.57 $191.80 $0.48 $99.58 $10.39 $5.93 $353.19 
A patient can be included in more than one line or show up multiple times in the 
same line in the current data.  We cannot compare the FY 2007 and 2008 costs to each 
other without first converting the 2007 and 2008 dollars into base year (BY) 2009 dollars. 
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Cost Comparison Analysis 
Net Present Value 
 We must establish some basic assumptions for cost/benefit analysis techniques.  
The net present value is a way of comparing the value of money now with the value of 
money in the future (Net Present Value, 2010).  Most economic analysis models 
incorporate a discount rate in order to determine the required return rate of investing 
capital.  The calculation of a discount rate is mathematically simple.  If a discount rate is 
5%, the present value of a good or service available in one year‟s time is 5% less than the 
present value of the same good available right now.  A dollar today is worth more than a 
dollar in the future, because inflation erodes the buying power of the future money (Net 
Present Value, 2010).  Discount rates, typically the Consumer Price Index (CPI), enable 
us to quantify the potential medical costs and benefits of paying expenses now versus 
later.  A major portion of the medical costs in this project is direct medical costs. 
Validating DoD Cost Factors 
Direct Medical Costs 
 This research project will focus solely on direct medical costs even though direct 
costs include both medical and disability costs.  Direct medical costs directly impact 
hospital finances because they are actual medical expenditures.  Disability costs are 
associated more with retired or medically discharged military personnel and the 
Department of Veterans Affairs typically disburses disability payments.  Thus, these 
costs will not be included in our research project.  In addition, reimbursements to civilian 
facilities for military health care will not be included.   
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The medical cost data are from July 2007- June 2008 for all Defense Health 
Programs (DHPs) (Army, Navy, and Air Force).  The data are from Active Duty 
personnel from 378 Military Treatment Facilities (MTFs) in FY08 and 341 MTFs in 
FY07.  The number of bed days is unknown and thus we cannot assign a cost to each 
patient based on bed days.  Then year dollars show the cost of the treatment in the year 
the care was received.  However, we cannot compare medical costs in the year they were 
captured to the current year medical costs because they are not weighted the same.  In 
order to compare the costs of medical care all dollars must be in a base year.  The 
following section addresses normalizing direct medical costs to ensure we are comparing 
dollars in the same year. 
 Normalizing Direct Medical Costs 
 Inflation changes the purchasing power of money and typically, goods and 
services increase over time due to inflation.   The Bureau of Labor Statistics (BLS) 
provides inflation factors for goods and services.  In order to conduct analysis on our 
data, we must normalize the medical costs.  The CPI enables us to compare prices from 
different years by distinguishing price increases due to inflation.  One way to see these 
differences is to use inflation indices.  However, the BLS does not have an inflation index 
for medical costs, so we must build one.   
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Table 6: CPI-M Base Year Conversion Factors (BLS.gov) 
Year 
Traditional 
CPI- 
Annual 
Index 
Value 
Traditional 
CPI- 
HALF1 
Traditional 
CPI- 
HALF2 
Traditional 
CPI Inflation 
Value HALF1 
Traditional 
CPI Inflation 
Value   
HALF 2 
Medical 
CPI- 
Annual 
Index 
Value 
Medical 
CPI- 
HALF1 
Medical 
CPI- 
HALF2 
Medical 
CPI 
Inflation 
Value  
HALF1 
Medical 
CPI 
Inflation 
Value  
HALF 2 
Medical CPI 
Normalization 
Factor 
1999 162 160.9 163.1 1.8% 2.4% 250.6 248.6 252.6 3.5% 3.5% 1.490 
2000 167.3 166 168.7 3.2% 3.4% 260.8 258.2 263.3 3.9% 4.2% 1.431 
2001 171.9 171.6 172.2 3.4% 2.1% 272.8 270.1 275.4 4.6% 4.6% 1.368 
2002 174.3 173.4 175.2 1.0% 1.7% 285.6 282.4 288.8 4.6% 4.9% 1.307 
2003 178.1 177.5 178.6 2.4% 1.9% 297.1 294.5 299.7 4.3% 3.8% 1.256 
2004 182.7 181.5 183.9 2.3% 3.0% 310.1 307.4 312.9 4.4% 4.4% 1.204 
2005 188.7 186.7 190.7 2.9% 3.7% 323.2 320.6 325.9 4.3% 4.2% 1.155 
2006 194.7 193.8 195.7 3.8% 2.6% 336.2 333.6 338.8 4.1% 4.0% 1.110 
2007 200.08 198.54 201.62 2.4% 3.0% 351.05 347.33 354.78 4.1% 4.7% 1.063 
2008 207.78 206.93 208.62 4.2% 3.5% 364.07 362.64 365.50 4.4% 3.0% 1.025 
2009 
 
205.204 
 
-0.8% 
  
373.29 
 
2.9% 
 
1.000 
 In order to build Figure 6, we divided the CPI-M cost index obtained from the 
Bureau of Labor Statistics for 1999-2008 by the inflation factor in 2009.  The BLS set 
1982-1984 as a base year equal to 100.  If there is any increase or decrease in prices since 
the base year there will be an increase or decrease in the base value.  For example, in 
Table 6, the inflation factors for years 1999 and 2009 (first half of 2009) are 250.6 and 
373.29 respectively.  We use Equation 1 to calculate the conversion factor to normalize 
then year costs to 2009 year costs: 
1+ ((Base Year Index Value – Then Year Index Value) / Then Year Index Value)         (1) 
For example, Equation 2 calculated the normalization factor for 1999: 
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      1 + ((373.29 - 250.6) / 250.6) = 1.490          (2) 
In order to convert then year medical cost dollars into current year dollars we use 
Equation 3: 
Normalized Medical Cost = Weighted CPI-M * Direct Medical Cost         (3) 
For instance, assume that the base year for an analysis is 2007. If the total medical cost to 
treat a patient were $3,469.90 in 2007, how much would it have cost in the first half of 
base year 2009 dollars (all else being equal)?  The answer based on the Medical Care CPI 
would be 1.063*$3,469.90, or 3,688.50 base year 2009 dollars. 
We are interested in the Medical Consumer Price Index (CPI-M) annual and semi-
annual inflation data for 2007-2009 because these are the years represented in our 
medical cost dataset.  Figure 6 displays the difference between traditional and medical 
inflation.  It is necessary to use the medical inflation rates because Figure and Table 6 
clearly show that medical costs rise faster that tradition inflation. 
In Figure and Table 6, it is important to note the significant drop in the first half 
of 2009 tradition inflation data.  Mr. Mark Vitner, an economist at Wells Fargo 
Economics Group, quoted to CNNMoney.com that “the drop in CPI is mainly due to 
lower gasoline prices and lower grocery store prices” (US Inflation Calculator, 2009).   
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Figure 6:  Semi-Annual Comparison of Medical and Traditional CPI Inflation 
(BLS.gov) 
 Inpatient versus Outpatient Medical Costs 
 The prior methodology enables us to develop direct medical costs resulting from 
PTSD and mTBI.  The available data shows inpatient and ambulatory costs.  Inpatient 
costs occur when a patient admits him or herself to a medical treatment facility and 
typically results in some number of bed days for a specific stay.  The inpatient costs were 
available through MHS Data Mart (M2) but are not broken out by bed days.  However, 
ambulatory costs do not result in bed days.  These costs are the result of an illness that 
may not be severe enough to admit the patient, such as a routine doctor appointment or 
“sick call”.  Typically, inpatient data are more expensive than ambulatory data because a 
person is admitted to the MTF, which usually means the illness is more severe. 
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The medical cost data we received does not provide information on the severity of 
the illness or injury.  Thus, it will be hard to decipher between a mild and moderate TBI.  
The medical costs associated with PTSD and mTBI must be assessed in order to 
determine if there is any significant different between the cases where PTSD alone is 
diagnosed and where PTSD and mTBI are diagnosed together. 
Data Aggregation 
 There are many different ways to aggregate medical data, but we chose to create 
different groups for PTSD, mTBI, PTSD and mTBI combined, and the diagnoses 
associated with PTSD and/or mTBI.  For example, a doctor diagnoses a patient with 
PTSD, depressive disorder, and amphetamine abuse.  The doctor diagnoses another 
patient with PTSD, atypical depressive disorder, and irritable bowel syndrome.  We 
separate out the depressive disorder, amphetamine abuse, atypical depressive disorder, 
and irritable bowel syndrome illnesses and document the costs so we can compare the 
cost of having PTSD to the cost of not having PTSD.  We use this method for 
determining the cost of mTBI and the combination of mTBI and PTSD. 
 In order to compare medical costs we created an eleven-step process.  Before 
configuring the data, we randomly selected ten percent of the data to withhold from our 
analysis in order to test our model.  Excel associated a randomly generated value to each 
line of data, in which we sorted the random values and selected ten percent of the data to 
withhold.  After separating out a portion of the data, we began the eleven-step process.  
Each process represents a query we ran in Microsoft Access. 
 Step 1: Identify each key (each line of data are a key) that contains the illness of 
interest (PTSD, mTBI, and a combination of the two) 
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 Step 2: Identify all the diagnoses associated with the illness of interest 
 Step 3: Identify all the diagnoses not associated with the illness of interest 
 Step 4: Identify all the keys with at least one of the diagnoses associated with the 
illness of interest 
 Step 5: Identify which keys are not associated with the illness of interest 
 Step 6: Create a list of the keys associated with the illness of interest but also have 
at least one diagnoses not associated with the illness of interest 
 Step 7: Use step 6 and create a list of the keys that only have the diagnoses 
associated with the illness of interest 
 Step 8: Calculate the average cost for the illness of interest 
 Step 9: Calculate the average cost for the diagnoses associated with the illness of 
interest but do not have the illness of interest 
 Step 10: Calculate the average cost for all other diagnoses not associated with the 
illness of interest 
 Step 11: Calculate the average cost for the entire dataset 
 After analyzing the hold out, we determined the hold out portion was a good 
representation of the entire dataset so we expanded the dataset to include more factors.  
We combined the 2007 and 2008 PTSD and mTBI inpatient and outpatient data with a 
sample set of the 2008 outpatient population data.  In order to keep track of the different 
sets of data we added the following columns: key, sheet, type (outpatient, inpatient), and 
hold out (given a zero or one).  The hold out (HO) was only for the 2008 population data.  
Table 7 displays the columns we added in our dataset, but is only a portion of the cost 
data we analyzed.  For a full description of the cost data, please reference Appendix 1.  
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Table 7 shows three lines of data from the 2008 sample set, the outpatient 2007 and 2008, 
and the inpatient 2007 and 2008 with their associated diagnoses and costs.   
Table 7: Sample of Data Analysis 
Key PTSD mTBI Both Sheet Type HO FY FM Dx1 Dx2 Dx3 Dx4 Dx5 Dx6 Dx7 Dx8 Total Cost 
1 4 4 3 2008 OP 1 8 5 V589 81601 7962           $232.66 
2 4 3 2 2008 OP 1 8 6 V589 8242             $0.00 
3 4 3 2 2008 OP 1 8 5 V589 8441 72690           $223.03 
400361 4 5 4 OP07_08 OP 0 7 10 3102 3101 95901           $217.60 
400362 5 4 4 OP07_08 OP 0 7 10 3102 71946 30981           $374.91 
400363 5 4 3 OP07_08 OP 0 7 10 3102 7234 30740 30981         $349.52 
462929 3 5 3 IP07_08 IP 0 8 7 8600 8052 95901 94224 3051 3510 E993 E8498 $6,108.92 
462930 3 3 3 IP07_08 IP 0 8 7 8771 82030 8500 8761 8911 94128 94428 94800 $8,493.74 
462931 4 4 3 IP07_08 IP 0 8 7 82330 8500 8760 9562 V4589 E9912     $15,161.94 
Figure 7 provides a visual example of our cost methodology.  Figure 7 
demonstrates how we separated out each line of data, also known as keys.  Each key has 
anywhere from one to eight diagnoses (DXs).  The inpatient 2007 and 2008 dataset 
contained 3592 lines of data.  The outpatient dataset contained 32,285 and 51,772 lines 
for 2007 and 2008, respectively.  The eleven-step process separates the keys enabling us 
to analyze mTBI and PTSD cost information.  We assigned each set of cost data we 
analyzed with a number as seen in the PTSD, mTBI and both columns of Table 7.  These 
same numbers are in Figure 7. 
If a key contained mTBI, we labeled that key with a number five.  This also 
includes any diagnoses in the same key as mTBI, as long as the key contains mTBI 
diagnoses.  For example, if the key contained mTBI, depression, and headaches, we 
would label the key with a five. 
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If a key contained diagnoses associated with mTBI but does not contain mTBI, 
we labeled the key with a number four.  To follow along with our example, we would 
look for keys with depression and headaches and then label them with the number four. 
We assigned the keys that contained both diagnoses associated with mTBI and 
diagnoses not associated with mTBI the number three.  These keys do not contain mTBI.  
If a key contained depression, headaches, and back pains, we would label it with a three 
because back pains are not associated with mTBI. 
We assigned everything else in the dataset a number two.  Anything we did not 
capture in numbers three through five, we labeled as a number two as pictured in Figure 
7. 
      
Figure 7: Process for Determining the Cost of mTBI 
Using Figure 8 as an example for PTSD, the number five represents any key with 
PTSD.  For example, a key contains PTSD, depression, and a fractured rib.  This key 
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would be a five.  If another key contained the diagnoses depression and a fractured rib, 
the key would be given a number four.  Another key may contain depression and a 
broken finger.  This key has diagnoses associated with PTSD but also contains other 
diagnoses not associated with PTSD.  We labeled these keys with a number three.  Any 
key labeled with a three or four does not contain PTSD.  Everything other key in the 
dataset not already accounted for is labeled with a number two. 
                
Figure 8: Process for Determining the Cost of PTSD 
  The numbers enabled us to change the text in a given column in Microsoft Access 
but keep the key the same.  Thus, we made a column for PTSD, mTBI, both, mTBI only 
and PTSD only as seen in Table 6.  Any row that contains a five in the PTSD column will 
have PTSD.  This applies to the other columns as well.  Any row that has a four in the 
PTSD column will have diagnoses associated with PTSD (but does not contain PTSD) 
and again, this applies to the other columns.  Once we set up our data, we pulled out the 
costs for each number pictured in Figure 7 and 8.        
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Figure 9 explains our methodology for analyzing costs when a patient has both 
mTBI and PTSD.  Figure 7 and 8 laid over each other creates Figure 9 and shows how we 
separated out mTBI costs from PTSD costs and were still able to calculate the cost of 
having both mTBI and PTSD.  We pulled the multiple numbers (3-5) in by different 
queries making it easy to decipher the different costs associated with same number.  By 
determining the cost of mTBI alone and PTSD alone, we are better able to decipher the 
cost of having PTSD in addition to mTBI and vice versa.       
 
Figure 9: Process for Determining the Cost of mTBI and PTSD 
 We added a key count to the queries so we could see how many keys were in each 
number mentioned in Figure 7, 8, and 9.  After running all the queries, we pulled out the 
important cost information.  We divided the cost data by the number of encounters to 
obtain the average cost data.  We will break out the results in the next chapter. 
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Testing the Means 
 In order to determine the validity of each query, we must test the means.  We use 
Equation 4 to calculate the z-value: 
1 2 1 2
2 2
1 1 2 2
( ) ( )
(( / ) ( / ))
X X
Z
n n
 
 
  


                       (4) 
 For Equation 4, 21  and 
2
2  are estimated using the sample variances (
2
is ) for our 
sample datasets, since 2is  is a consistent estimator of
2
i . 
Once we obtain the z-value, we use the conversion table to convert the z-value 
into a p-value and determine if our means are statistically different.  We assume µ1- µ2 is 
zero in order to determine if there is a statistical difference in the means.  Our null 
hypothesis is µ1= µ2 and our alternative hypothesis is µ1≠ µ2.  By using an alpha of 0.1, 
any z-value greater than ± 1.645 enables us to reject the null hypothesis.  If any p-values 
are greater than the significance level, (0.1), we cannot reject the null hypothesis. 
Chapter Summary 
In this chapter, we discussed how we collected and manipulated data into a usable 
form.  First, we converted all medical costs into BY09$.  Then we withheld ten percent of 
our data to ensure our model worked properly.  After determining the hold out data was a 
good representation of our dataset, we added more factors and ran the model again.  Once 
we calculated the average costs, we had our results.  In Chapter IV, we discuss more on 
how we use each model to specifically address the research questions mentioned in 
Chapter I. 
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Chapter IV:   Analysis and Results 
 
In this chapter, we provide analysis and results for each of the research questions 
detailed in Chapter I.  First, we explain the outpatient costs for PTSD, mTBI, and both 
combined.  Second, we explain the inpatient costs and our findings.  Third, we compare 
the 2007 and 2008 costs for PTSD, mTBI, and both combined to the population sample 
data to determine if the specified illnesses account for a majority of the total medical 
costs that occur each year. 
Medical Costs 
 As mentioned in Chapter III, we broke the medical costs out by mTBI, PTSD, and 
both for our inpatient and outpatient dataset.  The outpatient Figures below display the 
costs for the 2007 and 2008 outpatient data as well as the 2008 outpatient population 
data.  The inpatient Figures only display the 2007 and 2008 inpatient data because we 
could not obtain the 2008 inpatient population data. 
Outpatient PTSD Costs 
We want to determine how much PTSD is actually costing the DoD over a two 
year period and Table 8 shows all the 2007 and 2008 outpatient PTSD costs.  The 
average cost of PTSD is $340 per incidence.  During the two-year period, 66,619 patients 
were treated for PTSD and incurred a cost of $22.6 million.  Assuming the number of 
outpatient PTSD incidences are consistent throughout the war from 2003-2010, the DoD 
will incur a bill of $90.6 million for PTSD alone.  There are also long-term implications 
and costs associated with PTSD, but we could not capture these costs using our dataset.  
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While the diagnoses associated with PTSD and non-associated diagnoses and the 
costs of the dataset containing all other diagnoses not related to PTSD were higher, there 
were fewer incidences.  Based on the p-value, there is a statistical difference between the 
average cost of treating PTSD and the average cost of treating every other diagnosis not 
related to PTSD, see Appendix 6.  It is important to have the average costs of treating 
PTSD statistically different from the costs we are comparing them to because the 
difference is unlikely to have occurred by chance. 
Table 8: PTSD Outpatient Average and Total Costs 
Query OP Avg Cost N OP Total Cost 
PTSD $340 66,619 $22,641,177 
Dxs Associated with PTSD $313 7,543 $2,363,461 
Dxs Associated with PTSD & 
non-associated Dxs $369 9,486 $3,499,712 
Else-PTSD dataset $390 409 $159,309 
   Outpatient mTBI Costs 
Table 9 shows all the 2007 and 2008 outpatient mTBI costs.  The average cost of 
mTBI is $373 per incidence.  During the two-year period, 7,712 patients were treated for 
mTBI and incurred a cost of $2.88 million.  It is important to note that the lines of data 
that contained diagnoses associated with mTBI and diagnoses that are not associated with 
mTBI account for a huge medical cost.  Based on the p-value, there is a statistical 
difference between the average cost of treating mTBI and the average cost of treating 
every other diagnosis not related to mTBI, see Appendix 6.  The difference in costs is 
important because we are trying to prove the significance of the higher average cost of 
treating mTBI.  Assuming the number of outpatient mTBI incidences are consistent 
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throughout the war from 2003-2010, the DoD will incur a bill of $11.5 million for mTBI 
alone.  Just like PTSD, there are also long-term implications and costs associated with 
mTBI, but we could not capture these costs using our dataset.  
Table 9: mTBI Outpatient Average and Total Costs 
Query OP Avg Cost N OP Total Cost 
mTBI $373 7,712 $2,878,202 
Dxs Associated with mTBI $319 8,134 $2,592,992 
Dxs Associated with mTBI 
& non-associated Dxs $331 64,794 $21,459,946 
Else-mTBI dataset $354 3,417 $1,210,077 
Outpatient PTSD and mTBI Costs 
Table 10 explains the difference in average total cost when a person has PTSD, 
mTBI, or both combined.  It is interesting to note the lower average cost for having both 
PTSD and mTBI.  One reason for this could be the low number of people admitted to the 
outpatient clinic for PTSD and mTBI.  Most mTBI cases require more than just a brief 
check-up.  Table 10 shows there is a difference in the number of keys with PTSD and 
PTSD with mTBI as well as mTBI and mTBI with PTSD.  In our query for mTBI there 
were 763 keys that also contained PTSD.  In our query for PTSD, there were 763 keys 
that also contained mTBI, thus, we needed to pull queries for PTSD without mTBI and 
vice versa.  If a patient is diagnosed with both PTSD and mTBI versus PTSD only, on 
average, it costs an additional $6.37 per incidence.  We found it interesting that the 
average cost of a key containing mTBI and some PTSD codes was less than if the key 
only contained mTBI diagnoses.  Here again, many patients with mTBIs will most likely 
incur bed days when seeking medical treatment.  Table 10 supports this reasoning by the 
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massive occurrences of PTSD compared to mTBI.  Based on the p-value, there is a 
statistical difference between PTSD without mTBI and mTBI without PTSD.  There is 
also a statistical difference between mTBI without PTSD and both PTSD and mTBI.  
However, we cannot reject the null hypothesis when comparing PTSD without mTBI and 
both PTSD and mTBI, reference Appendix D.   
Table 10: 2007/2008 Outpatient PTSD and mTBI Average and Total Cost 
Differences 
Query OP Avg Cost N OP Total Cost 
PTSD without mTBI $340 66,619 $22,641,177 
PTSD-may contain mTBI Dxs $340 67,382 $22,901,662 
Both $346 763 $264,178 
mTBI-may contain PTSD Dxs $371 8,475 $3,148,269 
mTBI without PTSD $373 7,712 $2,878,202 
Inpatient mTBI Costs 
As mentioned in Chapter III, the inpatient data are much more costly than 
outpatient data because of bed days.  Thus, the inpatient cost of PTSD and mTBI is 
thousands of dollars more than the outpatient costs. 
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Figure 10: Average Cost of mTBI vs mTBI with PTSD 
 If a patient is diagnosed with mTBI without PTSD, on average, it will cost 
$10,983 to treat the patient, as shown in Figure 10.  In 2007 and 2008, 94 patients were 
treated for mTBI only, resulting in a cost of just over $1 million.  However, if the patient 
has PTSD, it will cost $560 more to treat the same patient.  That is a 4.9% increase per 
incidence.  While this increase may seem small, it is imperative to note that when we ran 
our queries, there were thirty-nine keys that contained PTSD when we pulled mTBI data.  
This results in an additional medical bill of $21,840 to properly care for these injured 
patients.  However, based on the p-value, there is not a statistical difference between 
mTBI without PTSD and mTBI, see Appendix D.  This may be because the costs were 
relatively similar. 
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Inpatient PTSD Costs 
         
Figure 11: Average Cost of PTSD vs PTSD with mTBI 
 Figure 11 displays the cost difference of when a patient is diagnosed with PTSD 
without any mTBI diagnoses and when the patient has PTSD and some mTBI diagnoses.  
In 2007 and 2008, 3,031 patients were treated for PTSD only.  This results in a cost of 
$33.2 million.  However, if the patient has mTBI, it will cost $24 more to treat the same 
patient.  It will cost $936 more to treat the thirty-nine patients diagnosed with PTSD 
when some of the same keys contain mTBI diagnoses.  The cost difference depicted in 
Figure 11 is much less than in Figure 10, $536 per incidence to be exact.  If a patient has 
mTBI with some PTSD diagnoses, it will cost $21,846 more to treat the patients than if 
they were diagnosed with PTSD and had some mTBI diagnoses.  Contrary to our 
literature review, it is more expensive for the patient to be treated for mTBI, when the 
patient may have PTSD as well. 
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Inpatient PTSD and mTBI Costs
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Figure 12: 2007/2008 Inpatient PTSD and mTBI Medical Costs 
 When we separate out PTSD and mTBI, we found that the average total cost is 
$10,946 and $10, 983, respectively.  If a patient was diagnosed with both PTSD and 
mTBI the average total cost rose to $12, 893, as depicted in Figure 12.  On average, when 
a person is diagnosed with both the cost increases $1,928 or 17.58% per incidence.   
Cost Comparison 
 We built our model on mainly mTBI and PTSD diagnoses, which is not an 
accurate representation of a year‟s medical diagnoses.  Everyday soldiers are diagnosed 
with illnesses unrelated to PTSD and mTBI, and our 2007 and 2008 mTBI and PTSD 
dataset do not account for these illnesses.  Thus, we want to know if our costs are 
comparable to an entire year of military medical diagnoses.   
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 Modeling Accuracy 
The following section attempts to validate the costs demonstrated in the 
Methodology section.  We offer a comparison by computing medical costs from a sample 
set of 2008 outpatient population data.  The 2008 outpatient population data consisted of 
more than two million lines of data.  We selected a sample set of the data to analyze and 
compare with our model.  We also withheld ten percent of the 2008 outpatient population 
data to ensure we had a fair representation of the dataset. 
 2008 mTBI only and PTSD only Sample Set Comparison 
 As with the 2007 and 2008 outpatient data, we broke the 2008 sample set data out 
by mTBI, PTSD, and both.  Table 11 represents the cost differences between the 
2007/2008 outpatient data, the 2008 hold out data, and the 2008 sample set data.  The 
three columns on the right are the costs for all incidences. 
The 2008HO mTBI only column is $13 more per incidence whereas the 2008 
mTBI only column is $80 less when compared to the 2007 and 2008 data.  While the 
costs of the diagnoses associated with mTBI are relatively low, there are a large number 
of keys associated with mTBI causing the cost to be massive.  The cost for diagnoses 
associated with PTSD work the same way.  However, these costs are even bigger, 
reaching almost $53.5 million in the 2008 sample dataset.  Keep in mind this is only two 
months of data for the 2008 and 2008 hold out dataset. 
In both the columns with associated and non-associated diagnoses, the 2008 hold 
out shows these costs as being higher than the 2007/2008 dataset.  This means that our 
queries tagged any key with mTBI and tagged any diagnoses associated with mTBI.  
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Then we ran another query and selected any of the diagnoses that are associated with 
mTBI but may not have mTBI. 
Table 11: mTBI Only and PTSD Only Versus 2008 Population and Hold Out Data 
Query OP Avg Cost 2008HO 2008 OP Avg Cost*N 2008HO*N 2008*N 
mTBI  $373 $386 $294 $2,878,202 $17,766 $528,430 
Dxs Associated with 
mTBI $319 $248 $190 $2,592,992 $3,758,027 $30,760,926 
Dxs Associated with 
mTBI & non-associated 
Dxs $331 $343 $203 $21,459,946 $6,263,257 $30,433,668 
Else-mTBI dataset $354 $306 $186 $1,210,077 $1,265,132 $4,600,095 
PTSD  $340 $344 $345 $22,641,177 $342,212 $2,086,714 
Dxs Associated with 
PTSD $313 $265 $196 $2,363,461 $8,193,076 $53,464,051 
Dxs Associated with 
PTSD & non-associated 
Dxs $369 $388 $167 $3,499,712 $1,704,245 $8,927,764 
Else-PTSD dataset $390 $310 $121 $159,308 $398,624 $795,471 
 Another interesting finding is the else rows.  These rows contain all keys not 
related to the illness of interest.  In the 2007/2008 dataset, other diagnoses were more 
expensive than mTBI and PTSD.  Whereas in the 2008 and 2008 hold out datasets, the 
cost of other diagnoses were relatively small compared to the mTBI and PTSD costs in 
the dataset. 
We tested for statistical differences in the 2008 sample PTSD without mTBI and 
the 2008 hold out PTSD without mTBI and found no difference, which means the hold 
out is a good representation of the sample set.  However, this was not the case for the 
2008 sample mTBI without PTSD and the 2008 hold out mTBI without PTSD. 
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2008 Both mTBI and PTSD Sample Set Comparison 
 Table 12 shows the cost differences per case and total overall cost between the 
three datasets.  The 2008 and 2008 hold out data for PTSD and PTSD keys that may 
contain mTBI cost more than these same diagnoses in the 2007/2008 dataset.  However, 
there are not as many incidences in the 2008 and 2008 hold out dataset which results in a 
lower total cost.  The mTBI results are different in that the 2008 dataset mTBI and mTBI 
keys that may contain PTSD are lower than the 2008 hold out and the 2007/2008 data.  
The 2008 hold out mTBI incidences cost more than the 2007/2008 mTBI incidences.  
Like the PTSD though, there are more incidences in the 2007/2008 dataset, which results 
in a higher total cost.   
Table 12: Both PTSD and mTBI Versus 2008 Population and Hold Out Data 
Query 
OP Avg 
Cost 2008HO 2008 
OP Avg 
Cost*N 2008HO*N 2008*N 
PTSD $340 $344 $345 $22,641,177 $342,212 $2,100,506 
PTSD-may contain 
mTBI Dxs $340 $344 $345 $22,901,662 $342,513 $2,115,319 
Both $346 $246 $274 $264,178 $246 $12,351 
mTBI-may contain 
PTSD Dxs $371 $384 $293 $3,148,269 $18,031 $541,004 
mTBI $373 $386 $294 $2,878,202 $17,766 $528,430 
We tested for statistical differences in the 2008 sample both and the outpatient 
both and found the means are not the same.  The mean for the outpatient both query and 
the mean mTBI query resulted in the means being statistically different, as seen in 
Appendix D. 
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When we combine PTSD and mTBI the costs should change.  We predicted they 
will increase but that is not the case.  The outpatient cost for PTSD and mTBI increased 
from only having PTSD but decreased from only having mTBI.  The 2008 and 2008 hold 
out cost for having PTSD only or mTBI only decreased when a patient had both.  It is 
important to note that there was only one incidence where a patient had both PTSD and 
mTBI in the 2008 hold out dataset represented in Table 12. 
Based on our hypothesis and dataset findings, we believe PTSD is over 
diagnosed, and failing to diagnose and treat mTBI increases lifetime monetary costs over 
the money saved by treating a false positive mTBI.  In order to determine if our 
hypothesis is accurate we looked at the average costs for treating patients with PTSD and 
any diagnoses associated to mTBI and compared these costs to the cost of treating both 
PTSD and mTBI.  Figure 13 shows that, on average, it only costs $4 more for an 
outpatient procedure to treat a patient for both PTSD and mTBI.  For the 2008 sample 
population and hold out datasets, it is cheaper to treat a patient with both PTSD and 
mTBI than to just treat them for PTSD when they also have diagnoses associated with 
mTBI.  Unfortunately, this does not apply to the inpatient treatment costs, which leads us 
to our limitations. 
 
Figure 13: Cost Difference in Treating PTSD with Assocaiated mTBI vs Treating 
Both PTSD and mTBI 
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Limitations 
Dataset 
As with any dataset, there are limitations and our project is no exception.  The 
first major limitation is that our medical cost data are not broken down by individual 
patient.  Since we did not have individual data, we cannot break the data out by age, 
gender, rank, or mechanism of injury.  In order to acquire individual patient data, one 
must process a research request through the Institutional Review Board (IRB).  The IRB 
process is in place to protect the rights and welfare of human beings.  We did not have 
the time to complete this process.  Our dataset is by ordered diagnoses, which means, a 
patient can be included in more than one line of data or show up multiple times in the 
same line of data.  Because the data are only gross financial data by clinic, we cannot 
compute costs per bed day.  There are also zero cost diagnoses within the dataset.  This 
means that the Current Procedural Terminology (CPT) codes used were zero weighted so 
there were no costs assigned but the encounter still occurred. 
Another dataset limitation is that we are unable to control for all the other 
diagnoses that affect medical costs.  We are focusing solely on PTSD and mTBI and this 
was the only data pulled from the Military Health System.  Numerous diagnoses occur 
more frequently, such as tobacco use disorder, and cost more due to the massive number 
of occurrences.  These types of diagnoses can skew our results and we cannot determine 
the effect they will have on our analysis.  Thus, we focus on PTSD and mTBI costs.  
However, there are multiple diagnoses per line with only one cost.  A patient may have 
PTSD, persistent insomnia, unspecified psychological circumstance, and alcohol abuse 
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issues with only one cost for the line of data.  We cannot break these costs out to show 
the cost of PTSD without the other diagnoses.  This is the same case for mTBI diagnoses. 
We originally received medical cost data with surgical and ICU costs.  These 
numbers skewed the data drastically.  While these factors are important, we chose to 
exclude them from our analysis.  We also excluded a portion of the 2008 population 
dataset because there were no diagnoses associated with the medical costs.  Since we 
could not attribute the costs to any diagnoses, we chose to exclude these costs. 
The ICD-9 codes are the diagnosis codes listed in our dataset.  While PTSD has a 
single code attached to the illness, mTBI does not.  There are multiple diagnoses for the 
symptoms of mTBI and each patient can exhibit “a different mix of symptoms and the 
symptoms themselves are highly subjective in nature” (Arciniegas, Anderson, Topkoff, & 
McAllister, 2005).  We based our selection of ICD-9 codes on the list used by Ommaya 
et al and the 2008 Invisible Wounds of War study Rand conducted.  After determining 
which ICD-9 codes to use for mTBI we combined them which enabled us to compare 
PTSD and mTBI costs and properly analyze the data.  
Another limitation is the military health system in general.  The accounting 
system “does not measure the value of true outputs; does not capture all DOD health care 
costs; is inconsistent in how labor costs are allocated; and is difficult to compare direct 
care to private care and care among the services” (Task force on the Future of Military 
Health Care Final Report).  It is difficult to portray actual PTSD and mTBI costs when 
they are not reported correctly, which is why the costs for PTSD, mTBI, and all the 
diagnoses associated and not associated with PTSD and mTBI looked the same in our 
findings. 
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We also have limitations with the number of keys in each query.  Table 13 
displays how many keys we obtained after running our queries mentioned in Chapter III.  
Each dataset contains a different number of keys.  Since the inpatient dataset was small to 
begin with, our N ranges from two to 3,185.  It is essential to note that in our 2008 hold 
out sample medical population data we only had one key with both PTSD and mTBI.  
This affected the significance test, since having only one or two data points leads to a 
sample variance that does not properly reflect the population variance.  However, we had 
forty-five keys in the 2008 sample medical population data, which may lead to a better 
representation of the population variance. 
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Table 13: Number of Keys per Query per Dataset 
Description of Query 2008 2008HO OP IP 
PTSD only 6092 995 66619 3031 
mTBI only 1800 46 7712 94 
Both only 45 1 763 39 
PTSD-may contain mTBI Dxs 6137 996 67382 3070 
mTBI-may contain PTSD Dxs 1845 47 8475 133 
Dxs Associated with PTSD 272524 30945 7543 190 
Dxs Associated with mTBI 162095 15169 8134 188 
Dxs Associated with both 27320 5681 39875 791 
Dxs Associated with PTSD-may contain mTBI Dxs 274181 30989 13598 246 
Dxs Associated with mTBI-may contain PTSD Dxs 172523 18192 61797 1598 
Dxs Associated with PTSD & non-associated Dxs 53391 4393 9486 369 
Dxs Associated with mTBI & non-associated Dxs 149963 18277 64794 3185 
Dxs Associated with both PTSD & mTBI and non-
associated Dxs 173611 19237 43419 2762 
Dxs Associated with PTSD & non-associated Dxs--may 
contain mTBI Dxs 51857 4350 3077 276 
Dxs Associated with mTBI & non-associated Dxs-may 
contain PTSD Dxs 141056 15706 13785 1861 
Else-PTSD only dataset 6571 1287 409 2 
Else-mTBI only dataset 24720 4128 3417 125 
Else-Both only dataset 137602 12701     
Else-PTSD dataset 6403 1285     
Else-mTBI dataset 23154 3675     
Model 
The 2008 outpatient population data contained numerous lines of data without 
diagnoses.  Some of these lines had massive costs associated with them but our model 
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was unable to account for them because they did not contain a diagnosis.  Therefore, we 
excluded these lines from our model. 
 Illness Timelines 
 Timeframes are very important for mTBIs.  Immediate treatment can prevent 
mTBIs from creating long-term medical issues.  However, there are instances where a 
person may not realize they sustained a mTBI and may not seek medical treatment.  
Some symptoms may not even appear until weeks after the injury is sustained, so it is not 
uncommon for a mTBI to go undiagnosed or misdiagnosed.  “It is also important to have 
rapid diagnosis and quickly implemented treatment of a TBI to prevent secondary injuries 
due to the chemical and physical changes to the brain that can accompany a TBI, swelling 
for example” (Adams, 2009).  By missing the immediate treatment window, the recovery 
time may be prolonged, there is potential for serious personal complications and setbacks, 
and the cost, both personal and financial, will most likely increase.  “A 1996 medical 
study showed that a behavior-related discharge from the military was 1.8 times more 
likely for a TBI patient than for a soldier without a TBI” (Adams, 2009).  If the mTBI is 
undiagnosed, military mTBI patients “may be liable for tens of thousands of dollars' 
worth of medical bills, on top of lost wages (Adams, 2009). 
Chapter Summary 
In this chapter, we laid out the cost per incidence and total cost for PTSD only, 
mTBI only, PTSD and mTBI, mTBI keys that may contain PTSD, and PTSD keys that 
may contain mTBI.  We found the inpatient costs are much higher than the outpatient 
costs but unfortunately because the diagnoses were not time ordered we could not 
calculate the cost of misdiagnosing PTSD and mTBI.  Now that we analyzed the data, we 
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continue our discussion of the results in the next chapter.  We provide some 
recommendations for the decision makers and offer areas of further research. 
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Chapter V:  Conclusions 
 
In this chapter, we discuss our results and the limitations of our findings in an 
effort to guide further research in this area.  In addition, we discuss how our findings can 
potentially result in policy implications.   
Conclusions 
 PTSD and mTBI are the signature wounds of the current war and we determined 
the cost of each illness reported in 2007 and 2008.  The two years of PTSD and mTBI 
data showed that 3,031 of the diagnosed people admitted to a military treatment facility 
had PTSD and 94 had mTBI, as shown in Table 14.  The outpatient data showed a 
massive number of PTSD lines of data.  While the number of lines of mTBI data in the 
outpatient dataset increased, the increase was not as pronounced as the increase in the 
number of PTSD lines.  In the 2008 population sample and hold out datasets, the PTSD 
and mTBI illnesses were relatively small because these datasets included every medical 
diagnosis that occurred in 2008.   
Table 14: Number of Lines of PTSD and mTBI in Each Dataset 
                        
72 
 
 Table 15 displays the cost for incidence for PTSD, mTBI, and both combined.  
For the inpatient data, it costs more to have both PTSD and mTBI than to have each one 
individually.  This is not the case for the 2008 Sample data and hold out data.  Further 
analysis would need to be conducted to determine why the cost is less when a patient has 
both versus each one individually. 
Table 15: Cost Per Incidence 
          
Table 16 displays the total cost for each illness of interest.  The costs are much 
higher for the inpatient and outpatient illnesses but this is because the dataset was mainly 
PTSD and mTBI diagnoses for 2007 and 2008.  It is important to note that there are long-
term consequences associated with PTSD and mTBI and with only two years of data, we 
could not capture these long-term costs.   
Table 16: Total Cost Per Illness 
         
The inpatient and outpatient costs are much larger than the 2008 sample data and 
hold out data.  The 2008 sample dataset is only two months worth of 2008 outpatient 
data.  In the population dataset, there are everyday occurrences of some ICD-9 codes.  
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Every military member is required to complete a PHA and consequently, the PHAs 
accounted for 2.54% of the dataset.  Even though PTSD and mTBI only account for a 
small percentage of illnesses diagnosed in 2008, they are very serious illnesses.   
Without proper diagnosis, these illnesses may cause irreversible damage and can 
lead to permanent symptoms.  If a person incurs repeated mTBIs over an extended period 
(i.e., months, years) there is the potential for cumulative neurological and cognitive 
deficits.   However, if a person incurs repeated mild TBIs within a short period (i.e., 
hours, days, or weeks) the results can be catastrophic or fatal (CDC).  A person with an 
untreated mTBI or PTSD may be forced to live with permanent symptoms such as 
irritability, anxiety, and depression (Traumatic Brain Injury: The Journey Home).  The 
National Institute of Neurological Disorders and Stroke noted that TBI can cause epilepsy 
and may increase the risk for Alzheimer‟s disease and Parkinson‟s disease as the person 
ages (Traumatic Brain Injury: Hope Through Research, 2002).  With the increasing 
number of mTBIs being diagnosed, the future medical costs for treating the lasting effects 
could be massive.  For example, over eight years, based on 2007 and 2008 PTSD and 
mTBI data, the DoD would hypothetically spend $132.7 million on inpatient treatment 
for PTSD and another $90.5 million in outpatient PTSD treatment costs for active duty 
alone.  Following along with this example, mTBI inpatient costs could reach $4.1 million 
and outpatient costs could reach $11.5 million.  With millions of dollars at stake for 
active duty personnel, we must also consider cost of treating veterans.  We are currently 
experiencing the medical costs for the lasting effects of PTSD in the Vietnam War era 
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and we believe the medical costs for mTBI could be worse.  It is better to confront the 
lasting effects of mTBI before they get out of hand. 
The Signature Wounds of War report by RAND mentions that from a societal 
perspective, within two years, evidence-based treatment will more than pay for itself for 
PTSD.  The costs from the RAND model came from treatment expenditures, lost 
productivity, and costs associated with suicide.  The cost savings come from enhanced 
productivity outcomes, lower risk of suicide, and less treatment episodes over the 
modeled time frame (Tanielian & Jaycox, 2008).  Unfortunately, to date, there is no 
model for determining the cost savings for treating mTBI. 
Future Research 
 Our research only focused on active duty medical costs.  An extension of this 
research could be performed to account for National Guard or Air Reserve medical costs.  
Another great opportunity for future research would be to obtain IRB approval and 
examine patients based on medical diagnosis versus actual diagnosis.  Diagnoses 
assigned chronologically could prove to be very useful in determining the cost of 
misdiagnosing PTSD and mTBI.  With this information, a cost model could be 
constructed and help decision makers forecast the costs of PTSD and mTBI.  
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Figure 14: Decision Tree for Medical Diagnoses 
Another area of research that we believe would be beneficial is to use patient data 
to build a decision tree, as represented in Figure 14.  The decision tree could model the 
doctor‟s diagnosis decision and the cost for the decision as well as the chance that the 
diagnosis could be something else.  Actual patient data could help determine if a patient 
was misdiagnosed with PTSD when they had mTBI and vice versa. 
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PTSD and mTBI are major medical issues that some soldiers are forced to deal 
with.  These illnesses can cause more long-term medical issues if not properly treated in a 
timely manner.  We owe it to our soldiers who are fighting for our freedom, to provide 
them with the proper medical care to give them a chance at a normal, healthy life. 
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Appendix B: mTBI Descriptions 
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Appendix C: Query Results 
  PTSD without mTBI Results 
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     PTSD Results 
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mTBI without PTSD Results  
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         mTBI Results 
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     Both PTSD and mTBI Results 
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